Resources from the same session
Targeting KRAS with checkpoint inhibitors
Presenter: L. Mezquita, ES
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast
Vaccine and adoptive cell therapy strategies for the treatment of KRAS mutant NSCLC
Presenter: M. Nagasaka, US
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast